Drug Profile
Research programme: allergy immunotherapeutics - Sanofi
Alternative Names: Food allergy vaccine - Immune Design/Sanofi; Grass pollen allergy vaccine - Immune Design/SanofiLatest Information Update: 23 Jul 2019
Price :
$50
*
At a glance
- Originator Sanofi
- Developer Immune Design; Sanofi
- Class Allergy immunotherapies; Food allergy immunotherapies
- Mechanism of Action Immunomodulators; Toll-like receptor 4 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Food hypersensitivity; Hypersensitivity
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for preclinical development in Food-allergy in USA
- 28 Jul 2018 No recent reports of development identified for preclinical development in Allergy in USA
- 16 Mar 2016 Interim immunogenicity data in Hypersensitivity presented at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2016)